Loading the company…
Loading the company…
㈜원광제약
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Jeonbuk, founded in 1992. Industry: Bio & Pharma. Revenue for 2025 was ₩28.9bn. It has 62 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2011-04-11 · latest registration 2006-04-04 · newest first
본 발명은 경옥고가미방 발효물을 함유하는 피로로 인한 질환의 예방 및 개선용 조성물에 관한 것으로, 본 발명의 경옥고가미방 발효물은 실험 동물을 이용한 체중변화 시험, 강제유영실험, 혈청중 유리 지방산 (FFA) 함량, 크레아티닌(Creatinine) 함량, 락트산 디히드로게나제(LDH) 함량 및 간조직 내의 글리코겐 농도 측정 실험 등을 통하여 피로회복 효과가 탁월함을 확인하여, 피로관련 질환의 예방 및 개선용 약학 조성물 및 건강기능식품으로 유용하게 사용될 수 있다.
본 발명은 당용액을 사용하여 생약원료를 추출하여 현탁액을 제조하는 신규한 우황청심원 현탁액의 제조방법에 관한 것으로, 본 발명에 의하면, 약효에 변화가 없으면서 복용시 이물감이 없고, 외관상 품질의 보존성이 우수하며, 단시간내에 효과를 발휘할 수 있는 우황청심원 현탁액이 제공될 수 있다. 우황청심원*현탁액*당용액*이물감
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|
Revenue —.
Operating margin —.
Net income —.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06